Libing Xiang

1.0k total citations
43 papers, 615 citations indexed

About

Libing Xiang is a scholar working on Reproductive Medicine, Oncology and Cancer Research. According to data from OpenAlex, Libing Xiang has authored 43 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Reproductive Medicine, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Libing Xiang's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Cervical Cancer and HPV Research (6 papers). Libing Xiang is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Cervical Cancer and HPV Research (6 papers). Libing Xiang collaborates with scholars based in China, Hong Kong and Sweden. Libing Xiang's co-authors include Huijuan Yang, Xuan Pei, Wei Jiang, Xuxia Shen, Xiaohua Wu, Shuang Ye, Xiaohua Wu, Yutuan Wu, Jiajia Li and Weiqi Sheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Libing Xiang

39 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libing Xiang China 15 219 215 202 127 126 43 615
Chiung‐Ru Lai Taiwan 14 131 0.6× 151 0.7× 118 0.6× 64 0.5× 103 0.8× 24 504
Shiho Asaka Japan 13 62 0.3× 165 0.8× 155 0.8× 125 1.0× 93 0.7× 56 571
Nadja Dornhöfer Germany 13 160 0.7× 283 1.3× 186 0.9× 61 0.5× 407 3.2× 31 866
Hana Vošmiková Czechia 12 71 0.3× 183 0.9× 136 0.7× 82 0.6× 52 0.4× 35 508
Toshinari Muramatsu Japan 11 80 0.4× 97 0.5× 100 0.5× 73 0.6× 68 0.5× 42 363
Min Sung An South Korea 12 75 0.3× 155 0.7× 91 0.5× 58 0.5× 151 1.2× 42 705
Birgit Volgger Austria 11 98 0.4× 257 1.2× 82 0.4× 45 0.4× 134 1.1× 17 644
Simone Punt Netherlands 11 120 0.5× 455 2.1× 152 0.8× 101 0.8× 93 0.7× 14 733
John Liang United States 13 77 0.4× 152 0.7× 157 0.8× 50 0.4× 22 0.2× 28 470
J.T. Soper United States 9 83 0.4× 165 0.8× 72 0.4× 54 0.4× 62 0.5× 14 417

Countries citing papers authored by Libing Xiang

Since Specialization
Citations

This map shows the geographic impact of Libing Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libing Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libing Xiang more than expected).

Fields of papers citing papers by Libing Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libing Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libing Xiang. The network helps show where Libing Xiang may publish in the future.

Co-authorship network of co-authors of Libing Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Libing Xiang. A scholar is included among the top collaborators of Libing Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libing Xiang. Libing Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Xuxia, et al.. (2024). Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers. British Journal of Cancer. 130(6). 987–1000. 4 indexed citations
3.
Deng, Ting, Kaijiang Liu, Liang Chen, et al.. (2023). A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study. Journal of Gynecologic Oncology. 34(3). 10 indexed citations
4.
Jiang, Wei, et al.. (2023). Targeting PI3Kα increases the efficacy of anti‐PD‐1 antibody in cervical cancer. Immunology. 170(3). 419–438. 8 indexed citations
5.
Zhan, Shaokang, Shuang Dong, Siying Huang, et al.. (2023). Finite-key analysis of decoy model semi-quantum key distribution based on four-state protocol. Acta Physica Sinica. 72(22). 220303–220303.
6.
Jiang, Wei, Yutuan Wu, Qianlan Yao, et al.. (2023). The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer. Cancer Letters. 556. 216064–216064. 21 indexed citations
7.
Ye, Shuang, Wei Chen, Yutuan Wu, et al.. (2022). Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features. Journal of Ovarian Research. 15(1). 43–43. 11 indexed citations
8.
Ye, Shuang, Yiyong Wang, Lei Chen, et al.. (2022). The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients. BMC Surgery. 22(1). 81–81. 5 indexed citations
9.
Pei, Xuan, Libing Xiang, Wei Chen, et al.. (2021). The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix. Gynecologic Oncology. 161(3). 779–786. 31 indexed citations
10.
Wu, Yutuan, Shuang Ye, Shyamal Goswami, et al.. (2020). Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients. BMC Cancer. 20(1). 173–173. 37 indexed citations
11.
Jiang, Wei, et al.. (2019). Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the PIK3CA -E545K Mutation. Molecular Cancer Therapeutics. 19(2). 337–347. 13 indexed citations
12.
Zhang, Xin, et al.. (2019). Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Ye, Shuang, Shuai Liu, Libing Xiang, Xiaohua Wu, & Huijuan Yang. (2019). 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications. BMC Cancer. 19(1). 226–226. 11 indexed citations
14.
Jiang, Wei, Shuai Liu, Yingying Zheng, et al.. (2018). The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer. Journal of Hematology & Oncology. 11(1). 139–139. 71 indexed citations
15.
Xiang, Libing, Wei Jiang, Shuang Ye, et al.. (2017). ERBB2 mutation: A promising target in non-squamous cervical cancer. Gynecologic Oncology. 148(2). 311–316. 29 indexed citations
16.
Xiang, Libing, Jiajia Li, Wentao Yang, et al.. (2015). Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive Carcinoma. PLoS ONE. 10(7). e0131790–e0131790. 23 indexed citations
17.
Xiang, Libing, Wei Jiang, Jiajia Li, et al.. (2015). PIK3CA mutation analysis in Chinese patients with surgically resected cervical cancer. Scientific Reports. 5(1). 14035–14035. 33 indexed citations
18.
Sheng, Weiqi, et al.. (2013). Primary extramammary Paget's disease of the vulva: The clinicopathological features and treatment outcomes in a series of 43 patients. Gynecologic Oncology. 129(2). 412–416. 48 indexed citations
19.
Xiang, Libing, Huijuan Yang, Jin Li, Xiaohua Wu, & Xiaoyan Zhou. (2011). Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III. Diagnostic Cytopathology. 40(10). 849–855. 8 indexed citations
20.
Wang, Honghai, et al.. (2005). Roles of the polypyrimidine tract and 3′ noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation. Archives of Virology. 150(6). 1085–1099. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026